Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Ski... ( DELRAY BEACH Fla. Feb. 11 /- Kay ...)

HOME >> MEDICINE >> NEWS

Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line

Date:2/11/2008

DELRAY BEACH, Fla., Feb. 11 /PRNewswire/ -- Kay Renz Public Relations has been retained by one of the country's leading cosmetic dermatologists, Peter G. Ballas MD, who has a thriving practice in prestigious Boca Raton, Florida. Dr. Ballas is highly regarded nationally as one of the foremost authorities on injectables. His talent with fillers has been long noted by the nation's leading cosmeceutical lines, who select him to debut their products. He is currently introducing Artefill (R), the long-lasting wrinkle reducer with great success in Palm Beach County. Dr. Ballas has also personally formulated an extensive skincare line to solve the most common and annoying skin care woes.

"It is an honor to be working with Dr. Ballas," states Kay Renz. "With over two decades of experience, he has developed a stellar reputation as an educator, not only for his patients, but with other doctors across the county. Dr. Ballas often dedicates time to train other physicians on the art of new cosmetic procedures. His talent and extensive knowledge make him an outstanding resource for the media who are looking for comprehensive information on the latest anti-aging topics."

Dr. Ballas, will quickly become an important resource because of his in depth understanding of all the cosmetic procedures available and the selection process that should be employed when choosing the best anti-aging regime for a patient. Dr. Ballas offers treatments such as collagen injections, chemical peels, Botox Cosmetic(R), Perlane(R), Cosmoplast(R), Restylane(R), the Palomar laser which offers Fractional Skin Tightening, vein treatments and hair removal and a variety of other state-of-the art treatments.

For those outside of the South Florida area who seek Dr. Ballas' expertise, his private skin care line will allow them to bring his ingenuity home. Personally formulated to solve the skin care issues that plague men, women and teens, the Peter G. Ballas II MD line utilizes cutting
'/>"/>

SOURCE Kay Renz Public Relations
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Divided We Fail to Ramp Up Efforts Leading Up to Maryland Primary
2. Leading Network of Aesthetic Service Providers Offers Unique Gift Ideas for Valentines Day
3. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
4. Divided We Fail to Ramp Up Efforts in Delaware Leading up to Super Tuesday
5. CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India
6. New Swedish science prize awarded to leading US cancer researcher
7. Leading IVF Practice to Open 11th New England Location
8. Long Term Care Insurance Leader Offers Advice on Preventing Dementia, the Leading Cause of Care Claims
9. Snap Fitness Launches Partnerships with Leading Online Health & Fitness Companies
10. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices and drugs, ... J. McCauley has been appointed Co-Lead Counsel in the ... Products Liability Litigation (Case 7:13-md-02434-CS). The Order, which was ... Counsel are to submit their proposal for the Court’s ...

(Date:5/23/2013)... 23 (HealthDay News) -- The sensation of itching is ... back to a small molecule released in the spinal ... Researchers say this molecule, known as natriuretic polypeptide ... central nervous system. Ultimately, this signal is experienced as ... mice are similar, the researchers concluded that a similar ...

(Date:5/23/2013)... May 23 (HealthDay News) -- A shortage of a ... departments across the United States to contain the spread ... The drug, isoniazid (INH), was first used in ... be the core of any first-line treatment for tuberculosis ... nine months, according to the U.S. Centers for Disease ...

(Date:5/23/2013)... news release is available in French . ... researchers have discovered a novel molecular mechanism that can ... diseases of abnormal growth. In the May 23 edition ... the University of Montreal explain how they found that ... prevents cells from dividing. , "Cells normally monitor the ...

(Date:5/23/2013)... 23, 2013) Aortic arch pulse wave velocity, a ... of disease of the vessels that supply blood to ... the June issue the journal Radiology . ... functional information about vessel compliance that may help determine ... said Kevin S. King, M.D., assistant professor of radiology ...

Breaking Medicine News(10 mins):Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2 Health News:Got an Itch? Mouse Study May Help Explain Why 2 Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2 Health News:Scientists discover how rapamycin slows cell growth 2 Health News:MRI-based measurement helps predict vascular disease in the brain 2

[0] U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation [0] Got an Itch? Mouse Study May Help Explain Why [0] Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report [0] Scientists discover how rapamycin slows cell growth [0] MRI-based measurement helps predict vascular disease in the brain

... May 26, 2010 Complete Genomics Inc., a third-generation ... a wholly owned member of the Roche Group (SIX: ... and analytics services to sequence and compare a patient,s ... like this allow researchers to compare the patient,s genome ...

... amounts in the gums, those tough pink tissues that hold the ... to develop an early, non-invasive test for gum disease, the No. ... quart of which people produce each day, but gingival crevicular fluid ... tooth. The study, the most comprehensive analysis of GCF to date, ...

... People undergoing bisphosphonate therapy to prevent or treat osteoporosis (a ... and possible adverse side effects on oral health, according to ... of the American Dental Association (JADA). , Use of ... bisphosphonate-associated osteonecrosis of the jaw (BON) that occurs spontaneously or ...

... ... at over 3,000 retail sites. , ... (PRWEB) May 26, 2010 -- Buckts Firefox Add-on delivers discounts and ... purchase. When a shopper visits an online retailer, clicking on the highlighted ShoppingBuckt ...

... ... $100,000 per-violation penalties , ... Alexandria, VA (Vocus) May 26, 2010 -- More than ten major retailers, representing ... offered by the National Association of Chain Drug Stores (NACDS) and RollStream. ...

... expected changes to oversight of supplement industry , WEDNESDAY, ... dietary herbal supplements has found trace amounts of lead, ... tested, plus myriad illegal health claims made by supplement ... , The levels of heavy metal contaminants did not ...

Cached Medicine News:Health News:Genentech uses Complete Genomics' human genome sequencing service to compare tumor and normal genome in patient with non-small cell lung cancer; results published in Nature 2 Health News:Some bisphosphonates users unfamiliar with drug's possible side effects on oral health 2 Health News:Retailers and Manufacturers Quickly Adopt Online Network to Address CPSIA Compliance 2 Health News:Retailers and Manufacturers Quickly Adopt Online Network to Address CPSIA Compliance 3 Health News:Many Supplements Said to Contain Toxins, Make False Health Claims 2

Genentech uses Complete Genomics' human genome sequencing service to compare tumor and normal genome in patient with non-small cell lung cancer; results published in Nature Little-known mouth fluid may lead to test for gum disease Some bisphosphonates users unfamiliar with drug's possible side effects on oral health A New Firefox Add-on Revolutionizes the Delivery of Discounts for Online Shoppers Retailers and Manufacturers Quickly Adopt Online Network to Address CPSIA Compliance Many Supplements Said to Contain Toxins, Make False Health Claims

(Date:5/23/2013)... The need to add tissue preserving therapies ... prominently at the 108 th Annual Meeting ... Diego. According to SonaCare Medical, a leader in ... the need for image-guided technologies to better identify ... minimally invasive ablative treatments, was addressed in the ...

(Date:5/23/2013)... May 23, 2013 Spring Bank Pharmaceuticals, Inc., a ... viral infections, today announced that it has initiated dosing ... investigational, once daily, oral therapy for the treatment of ... patients and is designed to assess both the safety ... a first-in-class drug for the treatment of chronic HCV ...

(Date:5/23/2013)... , May 23, 2013 Israel Brain ... 2013 , Israel,s 1 st ... 14 th -15 th in Tel Aviv ... innovative city in the world by the Wall Street ... BrainTech Israel 2013 will showcase the latest breakthroughs in ...

Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2 Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3 Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2 Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3

[0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients [0] Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference

... THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 ... Inc. (NYSE: PFE ) today announced new ... body of evidence supporting the efficacy and safety profile ... the United States (U.S.). Eighteen abstracts across four indications, ...

... May 25, 2011 Boston Scientific Corporation (NYSE: ... U.S. Food and Drug Administration (FDA) to market its 2.25 ... in vessels as small as 2.25 mm in diameter. The ... The PROMUS Stent features a thin-strut, open-cell design ...

Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....

The Prism Exophthalmometer provides precise measurement of patient's exophthalmos....

PLX40s, 40 Watt Sealed CO2 Laser System....

Both corneal topography and refractive error data are measured together in a single step to minimize alignment errors. Objective autorefractometry and autokeratometric readings of sphere, cylinder an...

Medicine Products:

Soflens 59 Prism Exophthalmometer 40 Watt Sealed CO2 Laser System OPD-Scan Refractive Power / Corneal Analyzer